Lifecore Biomedical, INC \de\ 10-K annual reports

Lifecore Biomedical, Inc. reports significant revenue and cash flow improvements for its transition period, despite ongoing net losses and internal control weaknesses.

Lifecore Biomedical, Inc. reported a significant net loss for fiscal year 2025, despite progress in strategic initiatives and capacity expansion.

Lifecore Biomedical's 10-K filing reveals a year of revenue growth and improved gross profit, alongside ongoing financial and operational challenges.

Lifecore Biomedical, Inc. has restated its financial statements for fiscal years 2021 and 2022 due to errors in accounting, revealing material weaknesses in internal controls.